DK1455761T3 - Farmaceutiske præparater til oral administration af heparin eller derivater deraf - Google Patents

Farmaceutiske præparater til oral administration af heparin eller derivater deraf

Info

Publication number
DK1455761T3
DK1455761T3 DK02791763T DK02791763T DK1455761T3 DK 1455761 T3 DK1455761 T3 DK 1455761T3 DK 02791763 T DK02791763 T DK 02791763T DK 02791763 T DK02791763 T DK 02791763T DK 1455761 T3 DK1455761 T3 DK 1455761T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical compositions
oral administration
heparin
derivatives
parnaparin
Prior art date
Application number
DK02791763T
Other languages
English (en)
Inventor
Roberto Villa
Mauro Ajani
Luigi Moro
Original Assignee
Cosmo Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cosmo Technologies Ltd filed Critical Cosmo Technologies Ltd
Application granted granted Critical
Publication of DK1455761T3 publication Critical patent/DK1455761T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK02791763T 2001-12-11 2002-12-03 Farmaceutiske præparater til oral administration af heparin eller derivater deraf DK1455761T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2001MI002599A ITMI20012599A1 (it) 2001-12-11 2001-12-11 Composizioni farmaceutiche per la somministrazione orale di eparina osuoi derivati, utili per la terapia di malattie infiammatorie dell'int
PCT/EP2002/013651 WO2003049721A1 (en) 2001-12-11 2002-12-03 Pharmaceutical compositions for the oral administration of heparin or derivatives thereof

Publications (1)

Publication Number Publication Date
DK1455761T3 true DK1455761T3 (da) 2009-01-12

Family

ID=11448679

Family Applications (2)

Application Number Title Priority Date Filing Date
DK08160486.0T DK1992338T5 (da) 2001-12-11 2002-12-03 Farmaceutiske sammensætninger til oral administration af heparin eller derivater deraf
DK02791763T DK1455761T3 (da) 2001-12-11 2002-12-03 Farmaceutiske præparater til oral administration af heparin eller derivater deraf

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK08160486.0T DK1992338T5 (da) 2001-12-11 2002-12-03 Farmaceutiske sammensætninger til oral administration af heparin eller derivater deraf

Country Status (18)

Country Link
US (1) US8642082B2 (da)
EP (2) EP1455761B1 (da)
JP (1) JP4634713B2 (da)
KR (2) KR101062687B1 (da)
CN (2) CN100490823C (da)
AT (1) ATE410148T1 (da)
AU (1) AU2002358082A1 (da)
CA (1) CA2465832C (da)
CY (1) CY1108625T1 (da)
DE (1) DE60229287D1 (da)
DK (2) DK1992338T5 (da)
ES (2) ES2386922T3 (da)
HK (1) HK1072181A1 (da)
IT (1) ITMI20012599A1 (da)
MX (1) MXPA04005710A (da)
PT (2) PT1992338E (da)
SI (1) SI1455761T1 (da)
WO (1) WO2003049721A1 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8895064B2 (en) 1999-06-14 2014-11-25 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
TR200200562T2 (tr) 1999-06-14 2002-05-21 Cosmo S.P.A Vücutta kontrollü şekilde salgılanabilen ve nahoş tadı önleyebilen ağızdan alınmaya mahsus farmasötik bileşimler
US8257744B2 (en) * 2000-07-07 2012-09-04 Laboratorios Farmacéuticos Rovi, S.A. Pharmaceutical forms for the release of active compounds
EP2060253A1 (en) 2007-11-14 2009-05-20 Laboratorios Farmaceuticos Rovi, S.A. Pharmaceutical forms for the release of active compounds
SE0201922D0 (sv) * 2002-06-20 2002-06-20 Ltp Lipid Technologies Provide Koagulationshindrande komposition (Anticoagulant Composition)
ATE552004T1 (de) 2005-11-30 2012-04-15 Istituto G Ronzoni Oral verabreichbare heparinderivate
RU2009113557A (ru) * 2006-09-12 2010-10-20 Космо Текнолоджиз Лтд (Ie) Фармацевтические композиции для перорального или ректального введения белковых веществ
KR100837558B1 (ko) 2007-04-30 2008-06-12 (주)아모레퍼시픽 이중으로 안정된 세라마이드 나노 캡슐 포함 에멀젼조성물, 그의 제조방법 및 이를 이용한 피부 화장료 조성물
US8802156B2 (en) 2007-11-14 2014-08-12 Laboratorios Farmacéuticos Rovi, S.A. Pharmaceutical forms for the release of active compounds
EP2213282A1 (en) 2009-01-30 2010-08-04 Laboratorios Farmaceuticos Rovi, S.A. Pharmaceutical forms for the release of active compounds
KR101291813B1 (ko) 2011-04-27 2013-08-02 임승택 친수성이 증가된 덱스트린-세라마이드 복합체 및 이의 제조방법
US10154964B2 (en) 2011-09-07 2018-12-18 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
KR20200037574A (ko) 2018-10-01 2020-04-09 (주)우리비앤비 헤파린을 포함하는 탈모방지용 화장료 조성물
EP3791884A1 (en) * 2019-09-16 2021-03-17 Oskar Bunz Combination of heparin and magnesium salt for the treatment of viral infections
CN110585164A (zh) * 2019-10-08 2019-12-20 苏州弘森药业股份有限公司 一种艾司奥美拉唑镁碳酸氢钠胶囊的制作方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6054313A (ja) 1983-09-01 1985-03-28 Terumo Corp 腸管吸収性ヘパリン組成物
JP2893191B2 (ja) 1988-11-08 1999-05-17 武田薬品工業株式会社 放出制御性マトリックス剤
IE61651B1 (en) 1990-07-04 1994-11-16 Zambon Spa Programmed release oral solid pharmaceutical dosage form
US5665379A (en) 1990-09-28 1997-09-09 Pharmacia & Upjohn Aktiebolag Lipid particle forming matrix, preparation and use thereof
DK0621032T3 (da) 1993-04-23 2000-10-23 Novartis Ag Lægemiddelform med reguleret afgivelse
US5665370A (en) * 1995-02-22 1997-09-09 Temple University Of The Commonwealth System Of Higher Education Compositions containing cockroach aggregation pheromones, their production and uses
FR2763848B1 (fr) * 1997-05-28 2000-01-28 Rhone Poulenc Rorer Sa Utilisation des heparines de bas poids moleculaire pour la prevention et le traitement du trauma du systeme nerveux central
IT1298575B1 (it) 1998-02-06 2000-01-12 Vectorpharma Int Composizioni farmaceutiche in forma di nanoparticelle comprendenti sostanze lipidiche e sostanze antifiliche e relativo processo di
US6423345B2 (en) * 1998-04-30 2002-07-23 Acusphere, Inc. Matrices formed of polymer and hydrophobic compounds for use in drug delivery
WO2000048589A1 (en) * 1999-02-22 2000-08-24 Emisphere Holdings, Inc. Solid oral dosage form containing heparin or a heparinoid in combination with a carrier
ITMI991316A1 (it) 1999-06-14 2000-12-14 Cip Ninety Two 92 S A Composizioni farmaceutiche orali a rilascio modificato di mesalazina
AU1594801A (en) 1999-11-12 2001-06-06 Emisphere Technologies, Inc. Liquid heparin formulation
EP1392272B1 (en) * 2001-05-11 2014-08-06 Merrion Research III Limited Permeation enhancers

Also Published As

Publication number Publication date
DE60229287D1 (de) 2008-11-20
CA2465832C (en) 2011-06-28
EP1455761B1 (en) 2008-10-08
CN100490823C (zh) 2009-05-27
CN1599600A (zh) 2005-03-23
SI1455761T1 (sl) 2009-02-28
ATE410148T1 (de) 2008-10-15
CA2465832A1 (en) 2003-06-19
EP1992338B1 (en) 2012-06-27
WO2003049721A1 (en) 2003-06-19
ES2386922T3 (es) 2012-09-06
KR101062687B1 (ko) 2011-09-06
JP4634713B2 (ja) 2011-02-16
ITMI20012599A1 (it) 2003-06-11
US8642082B2 (en) 2014-02-04
EP1455761A1 (en) 2004-09-15
AU2002358082A1 (en) 2003-06-23
PT1992338E (pt) 2012-07-30
US20050020539A1 (en) 2005-01-27
CY1108625T1 (el) 2014-04-09
CN1258360C (zh) 2006-06-07
KR100984801B1 (ko) 2010-10-04
EP1992338A3 (en) 2009-08-12
CN1839877A (zh) 2006-10-04
KR20040063989A (ko) 2004-07-15
PT1455761E (pt) 2008-12-17
MXPA04005710A (es) 2004-12-06
ES2312652T3 (es) 2009-03-01
DK1992338T3 (da) 2013-03-25
JP2005511718A (ja) 2005-04-28
EP1992338A2 (en) 2008-11-19
HK1072181A1 (en) 2005-08-19
DK1992338T5 (da) 2013-04-08
KR20090065556A (ko) 2009-06-22

Similar Documents

Publication Publication Date Title
HK1072181A1 (en) Pharmaceutical compositions for the oral administration of heparin or derivatives thereof
DK1656372T3 (da) 2,4-pyrimidindiaminforbindelser til anvendelse til behandling eller forebyggelse af autoimmunsygdomme
DK1656347T3 (da) Substituerede indolderivater til farmaceutisk sammensætning til behandling af luftvejssygdomme
CY1105362T1 (el) Παραγωγα σουλφοναμιδιου, η παρασκευη τους και η εφαρμογη αυτων ως φαρμακα
NO20042739L (no) Farmasoytiske sammensetninger av 5,6,14-triazatetracyklo(10.3.1.0(2,11).0(4,9))-heksadeca-2(11)3,5,7,9-pentan
LTC1781298I2 (lt) Farmacinės kompozicijos, turinčios benzoksazino, skirtos respiracinių ligų gydymui
EE05581B1 (et) Aripiprasooli ravimlahus peroraalseks manustamiseks
DK1196163T3 (da) Farmaceutiske sammensætninger til behandling af insulinresistens
IS7298A (is) Platínuafleiða lyfjasamsetningar
NO20035438L (no) Farmasoytisk formulering for effektiv administrering av apomorfin, 6aR-(-)-N-propyl-norapomorfin og deres derivater og prodrugs derav
NO20040356L (no) Indaneddiksyrederivater og deres andvendelse som farmasoytiske midler, intermediater og fremgangsmate for fremstilling.
DK1212312T3 (da) Hidtil ukendte derivater af flavoner, xanthoner og coumariner
SE0101932D0 (sv) Pharmaceutical combinations
DK0979079T3 (da) Anvendelse af tetrahydropyridinderivater til fremstilling af lægemidler til behandling af sygdomme, der medförer en demyelinisering
IS6956A (is) Sítrat salt af 5,8,14,-tríasatetrasýkló[10.3.1.02,11.04,9]-hexadeka-2(11),3,5,7,9-pentaen og lyfjafræðilegar samsetningar af því
DK1458413T3 (da) Farmaceutiske sammensætninger på b asis af azetidin-derivater
NO20054346L (no) Sammensetninger og fremgangsmater for forebygging og behandling av endotoksinrelaterte sykdommer og tilstander
ITRM20030363A1 (it) Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico di esse.
MA26982A1 (fr) Derives de 2h-1-benzopyran, procedes de preparation de ces derniers et compositions pharmaceutiques dans lesquels ils entrent.
ITMI20021881A1 (it) Composizioni farmaceutiche per il trattamento di infezioni da patogeni dell'apparato urinario.
DK1282599T3 (da) Disulfidderivater, der er egnede til behandling af allergiske sygdomme
EE200300465A (et) Püridoindolooni derivaatidel põhinevad farmatseutilised kompositsioonid
DE60108354D1 (de) 2H-1-Benzopyran-Derivative, Prozesse zu ihrer Herstellung und Pharmazeutische Zusammensetzungen
NO20014414L (no) Farmasöytisk blanding for forhindring eller behandling av sykdom assosiert med et overskudd av IL-12 produksjon
CY1105308T1 (el) Θepαπεια για υπep-ουρικαιμια